Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pump. Supplementary Tables
dataset
posted on 2022-09-21, 08:05 authored by Mikhail A Rojavin, Michaela Praus, Eileen Rogers, Fiona Glassman, Jutta Hofmann, Niraj C Patel, Michael J. Palumbo, Patricia L. Lugar, John Anderson, Charlotte Cunningham-Rundles, Richard L. Wasserman<p>Supplementary Table 1. </p>
<p>Median weekly dose levels for patients administering IgPro20 with the IWI and CP.</p>
<p>*Patient numbers differed for this row: Sequence 1 (CP/IWI): N=10; Sequence 2 (IWI/CP): N=12; Total: N=22</p>
<p>Abbreviations: CP, Crono S-PID-50 Infusion Pump; IWI, Investigational Wearable Infusor; SD, standard deviation.</p>
<p><br></p>
<p>Supplementary Table 2. </p>
<p>Device preference questionnaire (safety analysis set).</p>
<p>Footnotes: Subjects were allowed to choose up to three reasons for device preference.</p>
<p>Abbreviations: CP, Crono S-PID-50 Infusion Pump; IWI, Investigational Wearable Infusor.</p>
